Sunday, April 25, 2021

Biocon Biologics, Viatris receive EC nod for biosimilar Bevacizumab

Biocon Biologics, Viatris receive EC nod for biosimilar Bevacizumab The nod came following the positive recommendation by the Committee for Medicinal Products for Human Use of the European Medicines Agency, it said.

from Moneycontrol Business News https://ift.tt/3nneASz

No comments:

Post a Comment

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...